BioTech Medics, Inc., Engages Optininvestors, a Canadian Public Relations Firm

DALLAS, Nov. 21  /PRNewswire-FirstCall/ -- Keith Houser, CEO of BioTech Medics, Inc., (OTC Pink Sheets: BTMD) announced that BTMD signed a contract with Optininvestors.  "Optininvestors a public/investor relations firm has over 15 years experience helping companies.  Optininvestors has an extensive database of 25+ million investors and money managers, who have a high degree of interest in small companies," said Mr. Houser.  "In one week, Optininvestors has proven to the Board they can produce and perform."

BioTech Medics has entered into an agreement with a Pennsylvania company that was introduced by Optininvestors which intends to invest in BTMD's Pennsylvania 504 Reg D Exempt Offering filed in January 2005.  Originally, Hamilton Holding P.A., with Mr. William Seminario, President, represented by Adam Barnett (CEO) entered a contract and executed a $1 million Promissory Note.  In May 2005, BTMD declared a breach of the contract and default on the Promissory Note with less than $75k paid on the note.  Five Million shares were issued to Hamilton out of 25 million authorized.  Hamilton sold over 2.9 million shares prior to the breach/default.

"Prior to December 7, 2004, BTMD (formerly CBLH) was a shell corporation with zero income and assets.  Under new directors and management, BTMD has been successful in securing and creating $5.00 in assets for every 504 dollar raised through highly structured acquisitions," said Keith Houser, CEO.  "BTMD announced in September that BTMD was seeking to acquire a medical/office building in Dallas, Texas to add to the company asset base.  Negotiations are continuing.  The acquisition is expected to add a few more million dollars to BTMD's balance sheet.  The 504 share sale will allow the company to acquire more assets on BTMD's books, thus not diluting the stock value.  BTMD currently has over $2.5 million more in assets than in all of its previous 7 year history and over $700,000 in combined Gross Revenue which is $650,000 more than the company has previously earned annually (under Corbel management).  The company has millions in unrealized asset value from proprietary protocols and patent acquisitions this year, but due to Sarbanes- Oxley the company is restricted to book the assets at cost."

BioTech Medics operates a Pain Management & Wellness Center in Dallas; is a distributor for the NeuroLase Therapeutic Medical Laser and sells the patented SHBAN anti-mold, anti-mildew anti-bacterial Cleaning & Disinfectant Cleaner.  The company plans on 100 or more Pain Management centers nationwide.

Safe Harbor for Forward-Looking Statements.

This press release may contain forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"). In Particular, when used, the words "plan," "confident that," "believe," "scheduled," "expect," or "intend to," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act.  Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements.

Keith Houser, CEO of BioTech Medics, [phone] 

DATASOURCE: BioTech Medics, Inc.



CONTACT:  Keith Houser, CEO of BioTech Medics, Inc., [phone]



Web site:  http://www.biotechmedics.com/ 

Copyright